ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TTOO T2 Biosystems Inc

0.9635
-0.0045 (-0.46%)
Last Updated: 17:03:31
Delayed by 15 minutes
Share Name Share Symbol Market Type
T2 Biosystems Inc NASDAQ:TTOO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0045 -0.46% 0.9635 0.965 0.974 0.99 0.95 0.99 362,294 17:03:31

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

24/04/2024 2:00pm

GlobeNewswire Inc.


T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart


From Oct 2023 to Oct 2024

Click Here for more T2 Biosystems Charts.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2024 and business updates after market close on Monday, May 6, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 160751, approximately ten to five minutes prior to the start time.

About T2 Biosystems

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2Biothreat™ Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the Candida auris test, and the T2Lyme™ Panel. For more information, please visit www.t2biosystems.com.

Investor Contact:Philip Trip Taylor, Gilmartin Groupir@T2Biosystems.com415-937-5406

1 Year T2 Biosystems Chart

1 Year T2 Biosystems Chart

1 Month T2 Biosystems Chart

1 Month T2 Biosystems Chart

Your Recent History

Delayed Upgrade Clock